Mar 13, 2002
Is trizivir alone enough to start on? Should I be concerned about resistance down the road?
| Response from Dr. Young
Trizivir (AZT/3TC/abacavir) is a very convenient triple coformulated drug. The regimen has shown in several studies to be similar in potency to conventional protease inhibitor-based treatments for initial therapy. There has been some concerns about potency in persons with high (>100,000 copies) viral loads-- this was observed in a placebo-controlled study where patients took protease inhibitor placebo, so the benefit of low pill burden was not realized.
As for resistance, recent studies by Lanier have given us a lot of information about the patterns of resistance that emerge following viral failure of Trizivir-alone therapy. These data seem to indicate that the resistance that evolves early is quite similar to patterns that emerge following AZT/3TC-based treatments; largely resistance to the 3TC component. There is the potential danger that if treatment continued for a longer period of time (after initial failure), that additional nucleoside analogue resistance mutations will arise. This means that follow up lab testing is important, for this as well as other treatments.
In general, I have found the treatment to be very well tolerated and certainly among the most simple of three drug treatments available.
Hope this is helpful, BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.